JP2026035742A5 - - Google Patents
Info
- Publication number
- JP2026035742A5 JP2026035742A5 JP2025209848A JP2025209848A JP2026035742A5 JP 2026035742 A5 JP2026035742 A5 JP 2026035742A5 JP 2025209848 A JP2025209848 A JP 2025209848A JP 2025209848 A JP2025209848 A JP 2025209848A JP 2026035742 A5 JP2026035742 A5 JP 2026035742A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- fusion protein
- polypeptide chain
- protein according
- terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010393721.9A CN113637084B (zh) | 2020-05-11 | 2020-05-11 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
| CN202010393721.9 | 2020-05-11 | ||
| PCT/CN2021/092861 WO2021228052A1 (zh) | 2020-05-11 | 2021-05-10 | 生物大分子靶向特异性补体抑制剂及其制备方法与应用 |
| JP2022568638A JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Division JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026035742A JP2026035742A (ja) | 2026-03-04 |
| JP2026035742A5 true JP2026035742A5 (https=) | 2026-03-31 |
Family
ID=78415417
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Active JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
| JP2025209848A Pending JP2026035742A (ja) | 2020-05-11 | 2025-11-28 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568638A Active JP7834347B2 (ja) | 2020-05-11 | 2021-05-10 | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230348554A1 (https=) |
| EP (1) | EP4151659A4 (https=) |
| JP (2) | JP7834347B2 (https=) |
| CN (2) | CN113637084B (https=) |
| CA (1) | CA3178088A1 (https=) |
| WO (1) | WO2021228052A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114920849A (zh) * | 2022-03-09 | 2022-08-19 | 安徽省立医院(中国科学技术大学附属第一医院) | 一种靶向补体免疫抑制蛋白及其构建方法及应用 |
| TW202523706A (zh) * | 2023-11-13 | 2025-06-16 | 大陸商瀋陽三生製藥有限責任公司 | 一種靶向C3b的雙功能融合蛋白及其製備方法與用途 |
| CN121159642B (zh) * | 2025-11-20 | 2026-04-03 | 山东第二医科大学 | 补体c9迷你结合蛋白或其突变体及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
| JP5913980B2 (ja) * | 2008-10-14 | 2016-05-11 | ジェネンテック， インコーポレイテッド | 免疫グロブリン変異体及びその用途 |
| CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
| WO2017114401A1 (zh) * | 2015-12-31 | 2017-07-06 | 江苏匡亚生物医药科技有限公司 | 具有补体调节活性的重组补体因子h-免疫球蛋白融合蛋白及其制备方法与应用 |
| JP7793287B2 (ja) * | 2017-10-18 | 2026-01-05 | シーエスエル リミティド | ヒト血清アルブミン変異体およびその使用 |
| CA3100071A1 (en) * | 2018-05-16 | 2019-11-21 | Csl Limited | Soluble complement receptor type 1 variants and uses thereof |
| US20220009979A1 (en) * | 2018-08-22 | 2022-01-13 | Alexion Pharmaceuticals, Inc. | Fusion proteins and methods of treating complement dysregulation using the same |
| CN111018999B (zh) * | 2019-12-05 | 2022-07-12 | 沣潮医药科技（上海）有限公司 | 二聚体免疫融合蛋白、药物组合物和用途 |
-
2020
- 2020-05-11 CN CN202010393721.9A patent/CN113637084B/zh active Active
-
2021
- 2021-05-10 WO PCT/CN2021/092861 patent/WO2021228052A1/zh not_active Ceased
- 2021-05-10 JP JP2022568638A patent/JP7834347B2/ja active Active
- 2021-05-10 CA CA3178088A patent/CA3178088A1/en active Pending
- 2021-05-10 EP EP21804660.5A patent/EP4151659A4/en active Pending
- 2021-05-10 CN CN202180034009.2A patent/CN115515985A/zh active Pending
- 2021-05-10 US US17/998,367 patent/US20230348554A1/en active Pending
-
2025
- 2025-11-28 JP JP2025209848A patent/JP2026035742A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2026035742A5 (https=) | ||
| JP7446501B2 (ja) | 抗体の挿入可能な可変フラグメント及びｎｋｇ２ｄリガンドの改変されたａ１－ａ２ドメイン、及び非天然のｎｋｇ２ｄ受容体に結合する非天然のｎｋｇ２ｄリガンド | |
| US20240059751A1 (en) | Interleukin-2 variants and methods of uses thereof | |
| JP2023527049A5 (https=) | ||
| Li et al. | Self-masking in an intact ERM-merlin protein: an active role for the central α-helical domain | |
| Baldwin | Comparison of transferrin sequences from different species | |
| JP2023181445A5 (https=) | ||
| JP2021533779A5 (https=) | ||
| JP2023506454A5 (https=) | ||
| JP2023504914A5 (https=) | ||
| JP2021510162A5 (https=) | ||
| JP2023518596A5 (https=) | ||
| JP2023553697A5 (https=) | ||
| KR20140067944A (ko) | 항체 중쇄불변부위의 이종이중체 고효율 형성을 유도하는 ch3 도메인 변이체 쌍, 이의 제조방법, 및 용도 | |
| JP2009520463A5 (https=) | ||
| WO2018028635A1 (zh) | 一种寨卡病毒人源单克隆抗体及其应用 | |
| WO2014130722A1 (en) | Methods and compositions for treatment of forbes-cori disease | |
| JP2018538356A5 (https=) | ||
| JP2023528207A5 (https=) | ||
| JP2023545707A5 (https=) | ||
| JP2002514418A5 (https=) | ||
| JP2025527303A (ja) | Ｉｌ－１８融合タンパク質およびｉｌ－１８を産生する方法 | |
| JP2022522787A5 (https=) | ||
| Watanabe et al. | Binding site of annexin XI on the calcyclin molecule | |
| Kuo et al. | Orientation of type VI collagen monomers in molecular aggregates |